Content about Disability

April 17, 2014

Recognizing its dedication to the employment of persons with disabilities, United Cerebral Palsy on Thursday named Meijer “Employer of the Year.”

GRAND RAPIDS, Mich. — Recognizing its dedication to the employment of persons with disabilities, United Cerebral Palsy on Thursday named Meijer “Employer of the Year.” The 2014 Award for Excellence, announced at UCP’s Annual Conference in Nashville, Tenn., demonstrates the retailer’s steadfast commitment to diversity while helping people with disabilities reach their full potential through meaningful employment at Meijer. 

March 31, 2014

CVS Caremark has announced that it will be the National Premier Sponsor of Easter Seals Walk With Me in 2014 — its ninth straight year.

CHICAGO — CVS Caremark has announced that it will be the National Premier Sponsor of Easter Seals Walk With Me in 2014 — its ninth straight year.

Demonstrating its continued commitment to children with disabilities and their families through the All Kids Can Program, CVS Caremark and thousands of its colleagues nationwide have raised nearly $10 million through Walk With Me to support local Easter Seals services throughout the years.

March 19, 2014

Former SVP Walgreens Randy Lewis on Wednesday announced the release of his book "No Greatness without Goodness," which outlines the progression Walgreens has made in giving people with disabilities the opportunity for employment.

CHICAGO — Former SVP Walgreens Randy Lewis on Wednesday announced the release of his book "No Greatness without Goodness," which outlines the progression Walgreens has made in giving people with disabilities the opportunity for employment. 

According to Lewis, 1-in-5 Americans has a disability, and nearly 70% of people with disabilities and 95% with severe cognitive disabilities, such as autism, will never hold down a job. 

August 27, 2013

Walgreens CEO Greg Wasson was featured as a best-practice employer on a CNBC segment Tuesday afternoon on the hiring of Americans with disabilities.

NEW YORK — Walgreens CEO Greg Wasson was featured as a best-practice employer on a CNBC
segment Tuesday afternoon on the hiring of Americans with disabilities. Walgreens employs approximately 1,000 persons with disabilities throughout its supply chain, or 10% of its supply chain workforce. Wasson wants to hit that mark across its retail workforce as well, Wasson said.  

May 17, 2013

Safeway and the Safeway Foundation on Friday announced they raised and donated more than $10.8 million in April for Easter Seals, Special Olympics and a range of other charities that support people with disabilities.

PLEASANTON, Calif. — Safeway and the Safeway Foundation on Friday announced they raised and donated more than $10.8 million in April for Easter Seals, Special Olympics and a range of other charities that support people with disabilities.

This year's campaign brings the total donation from the annual Support for People with Disabilities campaign, along with other fundraising activities, to $150 million to benefit some of the most respected and prominent charities that help people with disabilities live fuller lives.

December 10, 2012

The Jean Coutu Group recently announced that it is acquiring a 50% stake in Le Groupe Médicus, which specializes in orthotic and prosthetic devices.

LONGUEUIL, Quebec — The Jean Coutu Group recently announced that it is acquiring a 50% stake in Le Groupe Médicus, which specializes in orthotic and prosthetic devices.

Financial terms of the deal were not disclosed.

Founded in 1957 by Jean-Claude Bleau, Médicus is a private-sector employer of orthotist and prosthetist graduates in Quebec and specializes in orthotic and prosthetic devices and rehabilitation products by completing the multidisciplinary treatment plan.

October 12, 2012

MS Trading’s Cleanlogic bath and body care line — which is dedicated to raising awareness, as well as funds for those who struggle with blindness — has announced the launch of its new Green Collection, a groundbreaking entry into the world of eco-friendly bath and body care.

NEW YORK — IMS Trading’s Cleanlogic bath and body care line — which is dedicated to raising awareness, as well as funds for those who struggle with blindness — has announced the launch of its new Green Collection, a groundbreaking entry into the world of eco-friendly bath and body care.

September 10, 2012

Some of the most commonly cited health problems affecting the elderly are hypertension, stroke and osteoporosis, but a new study highlights what researchers call an even bigger problem.

MINNETONKA, Minn. — Some of the most commonly cited health problems affecting the elderly are hypertension, stroke and osteoporosis, but a new study highlights what researchers call an even bigger problem.

Americans ages 65 years and older said that hearing impairment affects their quality of life physically and mentally more than high blood pressure, stroke, osteoporosis, sciatica and cancer, according to the study, released Thursday by AARP Services and UnitedHealthcare.

August 20, 2012

MISSISSAUGA, Ontario — Through the support of Rexall’s vendors and partners, Rexall’s annual vendor golf classic raised more than Canadian $250,000 for the Rexall Foundation earlier this month.

The Foundation for Prader-Willi Research received a C$10,000 donation at the Aug. 14 event.  The Foundation for Prader-Willi Research is an organization dedicated to eliminating the challenges of Prader-Willi Syndrome, a rare genetic disorder, through the advancement of research.

July 30, 2012

The Kessler Foundation and the Heldrich Center for Workforce Development last week released a research brief on disability employment titled “Strategies to Support Employer-Driven Initiatives to Recruit and Retain Employees with Disabilities” that explores the growing trend among employers in accommodating workers with disabilities.

WEST ORANGE, N.J. — The Kessler Foundation and the Heldrich Center for Workforce Development last week released a research brief on disability employment titled “Strategies to Support Employer-Driven Initiatives to Recruit and Retain Employees with Disabilities” that explores the growing trend among employers in accommodating workers with disabilities.

July 30, 2012

In July, the country’s largest trade group representing the drug industry released a report showing nearly 200 drugs under clinical development or Food and Drug Administration review for treating mental disorders.


In July, the country’s largest trade group representing the drug industry released a report showing nearly 200 drugs under clinical development or Food and Drug Administration review for treating mental disorders.


The Pharmaceutical Research and Manufacturers of America released a report listing 187 drugs, including 52 for depression, 37 for schizophrenia and 26 for anxiety disorders.


July 13, 2012

Nearly 200 drugs for mental illnesses are under clinical development or under review by the Food and Drug Administration, the largest lobbying group for the drug industry said Thursday.

WASHINGTON — Nearly 200 drugs for mental illnesses are under clinical development or under review by the Food and Drug Administration, the largest trade group for the drug industry said Thursday.

The Pharmaceutical Research and Manufacturers of America released a report listing 187 drugs, including 52 for depression, 37 for schizophrenia and 26 for anxiety disorders.

July 12, 2012

A clinical trial of a drug for schizophrenia did not yield the desired results, the drug's developer said.

INDIANAPOLIS — A clinical trial of a drug for schizophrenia did not yield the desired results, the drug's developer said.

Eli Lilly announced results of the H8Y-MC-HBBM study of pomaglumetad methionil, for patients with acute exacerbation of schizophrenia. The company said results did not show the drug produced a significantly different effect from the placebo.

June 22, 2012

A drug maker has resubmitted its new drug application to the Food and Drug Administration for an acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults.

MOUNTAIN VIEW, Calif. — A drug maker has resubmitted its new drug application to the Food and Drug Administration for an acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults.

Alexza Pharmaceuticals said it received a complete response letter for Adasuve last month from the regulatory agency. The CRL outlined the FDA's concerns about Alexza's manufacturing facility and the drug's draft product labeling. Alexza said it believes it has addressed these concerns in its resubmitted application.

June 18, 2012

Top-level executives from more than a dozen major U.S. companies on Monday joined with government officials to launch a nationwide public-private sector initiative to advance employment of people with disabilities.

WINDSOR, Conn. — Top-level executives from more than a dozen major U.S. companies on Monday joined with government officials to launch a nationwide public-private sector initiative to advance employment of people with disabilities. The companies and officials plan to work together to achieve common goals, including to identify and resolve employment barriers facing people with disabilities, share experience and best practices, raise visibility around the effort and awareness of the significant benefits, and expand participation.

April 24, 2012

Mylan has launched a generic drug for treating psychiatric disorders, the company said Tuesday.

PITTSBURGH — Mylan has launched a generic drug for treating psychiatric disorders, the company said Tuesday.

Mylan announced the launch of olanzapine tablets in the 2.5-mg, 5-mg, 7.5-mg, 10-mg, 15-mg and 20-mg strengths.

The drug, a generic version of Eli Lilly's Zyprexa, is used to treat schizophrenia and bipolar disorder. Various versions of the drug had sales of about $3.3 billion in 2011, according to IMS Health.

March 5, 2012

Indian drug maker Dr. Reddy's has launched a drug designed to treat bipolar disorder and schizophrenia, the company said.

HYDERABAD, India — Indian drug maker Dr. Reddy's has launched a drug designed to treat bipolar disorder and schizophrenia, the company said.

The company announced the launch of ziprasidone hydrochloride capsules in the 20-mg, 40-mg, 60-mg and 80-mg strengths.

The drug is a generic version of Pfizer's Geodon, which had sales of $1.34 billion in 2011, according to IMS Health.

September 7, 2011

After ending its five-week fundraising campaign to benefit the Muscular Dystrophy Association's efforts to develop treatments and assist people coping with neuromuscular diseases, Safeway announced that its stores raised $10.4 million for the organization.

PLEASANTON, Calif. — After ending its five-week fundraising campaign to benefit the Muscular Dystrophy Association's efforts to develop treatments and assist people coping with neuromuscular diseases, Safeway announced that its stores raised $10.4 million for the organization.

The campaign, which ran from Aug. 1 through Labor Day, marked Safeway's 10th annual fundraising effort. Safeway has raised more than $58 million for muscular dystrophy charities.

August 2, 2011

Safeway announced its 10th annual campaign to benefit the Muscular Dystrophy Association's efforts to develop treatments and assist people coping with neuromuscular diseases.

PLEASANTON, Calif. — Safeway announced its 10th annual campaign to benefit the Muscular Dystrophy Association's efforts to develop treatments and assist people coping with neuromuscular diseases.

January 24, 2011

An investigational schizophrenia drug appears effective in reducing agitation in patients with the disease, according to results of a late-stage clinical trial published in the British Journal of Psychiatry.

MOUNTAIN VIEW, Calif. — An investigational schizophrenia drug appears effective in reducing agitation in patients with the disease, according to results of a late-stage clinical trial published in the British Journal of Psychiatry.

Alexza Pharmaceuticals announced results of a phase-3 trial of the inhaled drug AZ-004 (loxapine), which showed statistically significant improvement in symptoms of agitation in patients compared with the placebo.

December 1, 2010

Derma e Natural Bodycare, a manufacturer of natural skin care products, has announced the continued support of the nonprofit Special Olympics Southern California.

SIMI VALLEY, Calif. — Derma e Natural Bodycare, a manufacturer of natural skin care products, has announced the continued support of the nonprofit Special Olympics Southern California.

This year, in addition to contributing funds, Derma e supported Ventura County's 2010 Summer Dance that celebrated the completion of its summer games. The company donated skin care products with optimal levels of antioxidants, vitamins, minerals and botanicals to help keep the athletes' skin healthy, nourished and protected while they played sports outdoors.

October 29, 2010

SILVER SPRING , Md. (Oct. 29) The Food and Drug Administration has approved a new drug for treating schizophrenia, the agency said Thursday.

The FDA announced the approval of Latuda (lurasidone hydrochloride), made by Fort Lee, N.J.-based Sunovion Pharmaceuticals. The drug is approved to treat adults with the disease, a mental illness that causes hallucinations, delusions, paranoia and disordered thinking and behavior.

October 28, 2010

The Food and Drug Administration has approved a new drug for treating schizophrenia, the agency...

SILVER SPRING, Md. The Food and Drug Administration has approved a new drug for treating schizophrenia, the agency said Thursday.

The FDA announced the approval of Latuda (lurasidone hydrochloride), made by Fort Lee, N.J.-based Sunovion Pharmaceuticals. The drug is approved to treat adults with the disease, a mental illness that causes hallucinations, delusions, paranoia and disordered thinking and behavior.

August 12, 2010

The companies working on more than half of the mental illness drugs under development are...

WASHINGTON The companies working on more than half of the mental illness drugs under development are clustered in four U.S. states, according to research by the largest lobby for the drug industry.

 

The Pharmaceutical Research and Manufacturers of America compiled a study showing that of the 313 drugs, 192 are under development by companies in New York, New Jersey, North Carolina and California. The drugs are in clinical trials or under review by the Food and Drug Administration, PhRMA said.

 

 

July 19, 2010

More than 300 medications for treating mental disorders are in development, according to a new...

WASHINGTON More than 300 medications for treating mental disorders are in development, according to a new report by a pharmaceutical industry lobbying group.